Monizen Forte with sheep estrosis

Abstract

The article presents the results of the commercial experiment on the testing of Monizen F orte drug (series 010618) with sheep estrosis. The work was carried out on 30 lambs of the North Caucasian breed, with a live weight of 25-30 kg and a high infestation by the larvae of nasopharyngeal gadfly (Oestrus ovis), which were divided into 2 experimental and one control groups (10 animals each). All animals of the experimental groups used the Monizen Forte drug in a dose of 1 ml per 20 kg of animal weight once individually intramuscularly (group 1 ) and orally with half the single norm of concentrated feed ( group 2). 14 days after the administration of Monizen Forte, at a dose of 1 ml per 20 kg of animal weight, a clinical examination of sheep from 2 experimental and one control groups was carried out, and it was found that in all sheep of 2 experimental groups the clinical signs of estrosis disappeared, while in the sheep of the control group, these clinical signs persisted. During the slaughter of 2 sheep from the 1^st experimental group and the opening of the nasal passages, the larvae of the nasopharyngeal gadfly (Oestrus ovis) were not found, which indicated the high effectiveness of the preparation.